about
Guidelines for the use and interpretation of assays for monitoring autophagyGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Neurocognition after paediatric heart surgery: a systematic review and meta-analysisMitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse)Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalitiesIntensive insulin therapy protects the endothelium of critically ill patientsGuidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European SocThe Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.The altered adrenal axis and treatment with glucocorticoids during critical illness.Reduced cortisol metabolism during critical illnessImpact of withholding early parenteral nutrition completing enteral nutrition in pediatric critically ill patients (PEPaNIC trial): study protocol for a randomized controlled trialHormonal and metabolic strategies to attenuate catabolism in critically ill patients.Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?Effect of tight glucose control with insulin on the thyroid axis of critically ill children and its relation with outcomeThe role of insulin therapy in critically ill patients.The neuroendocrine response to critical illness is a dynamic process.Intensive insulin therapy in the intensive care unit: update on clinical impact and mechanisms of action.Endocrine aspects of acute and prolonged critical illness.Diabetes of injury: novel insights.Tight blood glucose control is renoprotective in critically ill patientsTherapy insight: the effect of tight glycemic control in acute illness.Intensive insulin therapy in high-risk cardiac surgery patients: evidence from the Leuven randomized study.Indication and practical use of intensive insulin therapy in the critically ill.Tight blood glucose control with insulin in the ICU: facts and controversies.Impact of early parenteral nutrition on metabolism and kidney injuryTight blood glucose control: what is the evidence?Glycaemic control and perioperative organ protection.The importance of strict blood glucose control with insulin therapy in the intensive care unit.Insulin treatment in intensive care patients.Metabolic aspects of critical illness polyneuromyopathy.Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness.Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulin.Critical illness-induced dysglycemia and the brain.Circulating phthalates during critical illness in children are associated with long-term attention deficit: a study of a development and a validation cohort.Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial.Glycemic control and outcome related to cardiopulmonary bypass.Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition.AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin.Glucose homeostasis, nutrition and infections during critical illness.Mitochondrial and endoplasmic reticulum dysfunction and related defense mechanisms in critical illness-induced multiple organ failure.
P50
Q21996341-B33DB9FE-C029-498A-83FB-BE8C9CE01394Q22676705-9DAD2C6E-0D21-43C4-B662-9EAB5694B8E7Q26777069-EC803151-F76D-476A-A20B-CC5BC67DE7EFQ28360949-25A4A213-F3AC-4A45-9980-62324856659AQ28508098-6849335A-0D6F-4A6B-983E-E54BBA3B5A66Q33905796-5C0DD5BE-E4AE-4389-9A05-FE3DC1137291Q34092420-D3FD80A1-BFFD-45C5-9014-3706C3F09570Q34483183-7F936A26-C6A5-4646-AD87-25A4D4FB38F1Q34807379-5B583A32-839E-420C-A41B-359E44071D69Q35549611-9E38308F-4BD9-437A-B08E-13B7A3F6CEC0Q35576744-1B4E1717-33EA-4AA4-881F-FCCFF38705E8Q35938762-C3C0A8C3-FBCE-47B8-9C2D-8AB38B63D219Q36193319-C5A58048-A59D-4116-942C-A7038FF40787Q36293600-E44EBF95-C60E-4C88-B9E5-2B9B82A81068Q36327013-69DDE86D-0962-4D2C-9182-44AF06D6F57EQ36362881-2F7AFEE8-9084-4A90-8263-45F70B35B4FAQ36564529-2B3DCA79-3248-4F91-95BE-F2B91C598222Q36576950-3F9659F8-D9D6-4E87-A408-26F4285149BEQ36663963-E0821BAE-79DF-4143-A781-52FD04AB5DD8Q36667192-86E1B8CE-13F9-499C-BB14-9A01D0FEABC2Q36742049-7ECE222E-23C9-49BA-83FB-AD2077E95036Q36774514-33CCF273-EDD1-4F15-ADB4-4E377C5AFB87Q36863943-5EEA2AC3-3E53-4DF8-8F3F-2C99BA66775DQ36877475-72D213C1-E845-41B3-92D7-06FE6A1E4764Q36880413-2EF47A45-968B-4767-9657-702903E030F5Q36916490-205C09A6-FBE6-46EE-B108-933959D02444Q37169536-276C73A3-0AD3-4B54-87C8-FDE010AB2E8AQ37239292-6E0CED62-9D6D-4330-880C-9F07B351EFEAQ37336571-8B0E51EA-5DF6-4C4D-8E05-3CE68A4AA5BBQ37666366-75B422F5-F288-44F6-86AE-157B18AA33BEQ37667505-A8E5061A-E39B-4254-BDBE-910C695BD867Q37682835-BEA65855-020D-450F-B3C7-2EDD31BAEF1FQ38281435-86751498-0E7C-4830-BD3F-B933C0EA94E4Q38398460-A64C857D-09D2-4AD0-877E-F5C024D1B9D2Q38462086-9D8ACE56-FB16-4F71-A681-1A83E414B718Q38523055-4A43BFA8-D2E5-4649-B7D6-1629D3DCB8C5Q38802352-88FDF04A-35C8-44A2-B629-F432CEE4F7DBQ38994344-7A134921-20EC-47EB-9B3B-89F4D6C71E3AQ39084388-4051F752-C4A0-4326-B18A-0367BB684028Q39144659-AC393A77-84C3-4DCF-B94D-2977F14EB8C8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ilse Vanhorebeek
@ast
Ilse Vanhorebeek
@en
Ilse Vanhorebeek
@es
Ilse Vanhorebeek
@nl
Ilse Vanhorebeek
@sl
type
label
Ilse Vanhorebeek
@ast
Ilse Vanhorebeek
@en
Ilse Vanhorebeek
@es
Ilse Vanhorebeek
@nl
Ilse Vanhorebeek
@sl
prefLabel
Ilse Vanhorebeek
@ast
Ilse Vanhorebeek
@en
Ilse Vanhorebeek
@es
Ilse Vanhorebeek
@nl
Ilse Vanhorebeek
@sl
P106
P1153
8546362100
P21
P31
P496
0000-0002-5261-5192